ym 529 has been researched along with acetic acid in 1 studies
*Acetic Acid: Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed) [MeSH]
*Acetic Acid: Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed) [MeSH]
| Studies (ym 529) | Trials (ym 529) | Recent Studies (post-2010) (ym 529) | Studies (acetic acid) | Trials (acetic acid) | Recent Studies (post-2010) (acetic acid) |
|---|---|---|---|---|---|
| 140 | 23 | 71 | 11,160 | 293 | 4,594 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kakimoto, S; Mori, M; Nagakura, Y; Okada, M; Sasamata, M; Shibasaki, K; Tamura, S; Tanaka, S; Watabiki, T | 1 |
1 other study(ies) available for ym 529 and acetic acid
| Article | Year |
|---|---|
Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X(2/3) receptor function and exerts an analgesic effect in pain models.
Topics: Acetic Acid; Adenosine Triphosphate; Analgesics, Non-Narcotic; Animals; Bone Density Conservation Agents; CHO Cells; Cricetinae; Cricetulus; Diphosphonates; Disease Models, Animal; Dose-Response Relationship, Drug; Formaldehyde; Imidazoles; Injections, Subcutaneous; Male; Mice; Mice, Inbred ICR; Pain; Pain Measurement; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X2; Receptors, Purinergic P2X3; Time Factors; Transfection | 2008 |